LZTR1 and ovarian carcinoma: However, the CPTAC dataset showed no significant difference between tumor and normal tissues in terms of the expression of LZTR1 in breast cancer (P = 0.25), ovarian cancer (P = 0.20), and glioblastoma multiforme (GBM, P = 0.63).